{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:33:43Z","timestamp":1786732423436,"version":"build-2736575974"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Regional research support, Region Sk\u00e5ne","award":["2025-2024-2690"],"award-info":[{"award-number":["2025-2024-2690"]}]},{"name":"Regional research support, Region Sk\u00e5ne","award":["2022-1284"],"award-info":[{"award-number":["2022-1284"]}]},{"name":"Governmental funding of 390 clinical research within the Swedish National Health Service","award":["022:YF0009 and 391 2022-0075"],"award-info":[{"award-number":["022:YF0009 and 391 2022-0075"]}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","award":["2021-083"],"award-info":[{"award-number":["2021-083"]}],"id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lions Sk\u00e5ne research grants"},{"name":"Sk\u00e5ne University Hospital grants"},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["2022-0352 and 2022-045"],"award-info":[{"award-number":["2022-0352 and 2022-045"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017237","name":"Hans-Gabriel och Alice Trolle-Wachtmeisters stiftelse f\u00f6r medicinsk forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017237","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Swedish National Health Service","award":["022-0226"],"award-info":[{"award-number":["022-0226"]}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["0210233 and 2102332"],"award-info":[{"award-number":["0210233 and 2102332"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sk\u00e5ne University Hospital grants"},{"DOI":"10.13039\/501100017237","name":"Hans-Gabriel och Alice Trolle-Wachtmeisters stiftelse f\u00f6r medicinsk forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is a major public health challenge, and reliable biomarkers are essential for distinguishing sepsis from other conditions. Neutrophil Gelatinase-Associated Lipocalin (NGAL) has shown promise as a diagnostic marker due to its role in the immune response. This study evaluates plasma NGAL as a diagnostic tool at the time of ICU admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed plasma NGAL and C-reactive protein (CRP) levels in 2950 adult patients admitted to four ICUs between 2015 and 2018. All patients were retrospectively screened for Sepsis-3 criteria at ICU admission. The discriminative performance of NGAL and CRP for sepsis was assessed using receiver operating characteristic (ROC) analysis, with NGAL levels adjusted for chronic kidney disease (CKD) and age. Patients were stratified by renal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Plasma NGAL levels were significantly higher in septic patients (p\u2009&lt;\u20090.001). For the whole cohort, NGAL alone yielded an area under the curve (AUC) of 0.66 (confidence interval (CI) 0.64\u20130.68), CRP yielded an AUC of 0.71 (CI 0.69\u20130.73, p\u2009&lt;\u20090.001), and combining NGAL with CRP nominally improved discriminative performance (\n                      <jats:inline-formula id=\"pone.0343752.e001\">\n                        <jats:alternatives>\n                          <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" id=\"pone.0343752.e001g\" mimetype=\"image\" position=\"anchor\" xlink:href=\"info:doi\/10.1371\/journal.pone.0343752.e001\" xlink:type=\"simple\"\/>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" display=\"inline\" id=\"equation1\">\n                            <mml:mrow>\n                              <mml:mo>\u0394<\/mml:mo>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      AUC 0.018, 95% CI 0.011\u20130.027). Stratified analyses indicated that NGAL, together with CRP, significantly outperformed CRP alone in patients with no kidney injury and those with Acute Kidney Injury (AKI) only. In contrast, differences were not significant in patients with CKD only or CKD and AKI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large cohort, NGAL showed modest discrimination for sepsis, with a nominal improvement when combined with CRP. These findings do not indicate that NGAL meaningfully improves sepsis diagnosis in the ICU.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0343752","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:55:38Z","timestamp":1786730138000},"page":"e0343752","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neutrophil gelatinase-associated lipocalin (NGAL) is a poor diagnostic marker for sepsis in the ICU \u2013 An observational multicentre study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-7167","authenticated-orcid":true,"given":"Lisa","family":"Bostr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1421-3640","authenticated-orcid":true,"given":"Jonas","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-0402","authenticated-orcid":true,"given":"Anders Olof","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lengquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Frigyesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"8","key":"pone.0343752.ref001","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"C Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0343752.ref002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: time for a reappraisal","volume":"24","author":"C Pierrakos","year":"2020","journal-title":"Crit Care"},{"issue":"14","key":"pone.0343752.ref003","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","article-title":"Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase","volume":"268","author":"L Kjeldsen","year":"1993","journal-title":"J Biol Chem"},{"issue":"13","key":"pone.0343752.ref004","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.3390\/ijms241310470","article-title":"The review of current knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)","volume":"24","author":"K Romejko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0343752.ref005","doi-asserted-by":"crossref","first-page":"112002","DOI":"10.1016\/j.biopha.2021.112002","article-title":"Lipocalin-2: structure, function, distribution and role in metabolic disorders","volume":"142","author":"SA Jaberi","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"pone.0343752.ref006","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2215\/CJN.00980110","article-title":"The origin of multiple molecular forms in urine of HNL\/NGAL","volume":"5","author":"L Cai","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"pone.0343752.ref007","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"DH Goetz","year":"2002","journal-title":"Mol Cell"},{"key":"pone.0343752.ref008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13054-016-1212-x","article-title":"Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis","volume":"20","author":"A Zhang","year":"2016","journal-title":"Crit Care"},{"key":"pone.0343752.ref009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0004563214521795","article-title":"Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status","volume":"51","author":"A Haase-Fielitz","year":"2014","journal-title":"Ann Clin Biochem"},{"issue":"10474","key":"pone.0343752.ref010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(24)02385-7","article-title":"Acute kidney injury","volume":"405","author":"M Ostermann","year":"2025","journal-title":"Lancet"},{"key":"pone.0343752.ref011","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","article-title":"Biomarkers of renal function, which and when?","volume":"438","author":"ME Wasung","year":"2015","journal-title":"Clinica Chimica Acta"},{"issue":"9466","key":"pone.0343752.ref012","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"J Mishra","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"pone.0343752.ref013","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2006080882","article-title":"Dual action of neutrophil gelatinase-associated lipocalin","volume":"18","author":"KM Schmidt-Ott","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"pone.0343752.ref014","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1097-2765(02)00710-4","article-title":"An iron delivery pathway mediated by a lipocalin","volume":"10","author":"J Yang","year":"2002","journal-title":"Mol Cell"},{"issue":"4","key":"pone.0343752.ref015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3892\/etm.2021.9817","article-title":"Meta-analysis of the diagnostic value of serum, plasma and urine neutrophil gelatinase-associated lipocalin for the detection of acute kidney injury in patients with sepsis","volume":"21","author":"H Zhou","year":"2021","journal-title":"Exp Ther Med"},{"issue":"6","key":"pone.0343752.ref016","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","article-title":"Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup","volume":"19","author":"A Zarbock","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"pone.0343752.ref017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12882-015-0003-y","article-title":"Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis","volume":"16","author":"J Vanmassenhove","year":"2015","journal-title":"BMC Nephrol"},{"issue":"3","key":"pone.0343752.ref018","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00134-009-1724-9","article-title":"Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness","volume":"36","author":"SM Bagshaw","year":"2010","journal-title":"Intensive Care Med"},{"issue":"4","key":"pone.0343752.ref019","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/1354750X.2013.787460","article-title":"Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction","volume":"18","author":"J M\u00e5rtensson","year":"2013","journal-title":"Biomarkers"},{"issue":"3","key":"pone.0343752.ref020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5005\/jp-journals-10071-24419","article-title":"Role of Neutrophil Gelatinase-associated Lipocalin (NGAL) and other clinical parameters as predictors of bacterial sepsis in patients presenting to the emergency department with fever","volume":"27","author":"A Paul","year":"2023","journal-title":"Indian J Crit Care Med"},{"issue":"5","key":"pone.0343752.ref021","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/nep.12796","article-title":"Plasma Neutrophil Gelatinase-Associated Lipocalin diagnosed acute kidney injury in patients with systemic inflammatory disease and sepsis","volume":"22","author":"A Md Ralib","year":"2017","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"pone.0343752.ref022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00431-025-06017-8","article-title":"Enhanced mortality prediction in pediatric sepsis using NGAL: a comparison with PRISM III scores in critical care settings","volume":"184","author":"MI AbdelRazic","year":"2025","journal-title":"Eur J Pediatr"},{"issue":"6","key":"pone.0343752.ref023","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s13054-014-0634-6","article-title":"Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study","volume":"18","author":"M Wang","year":"2014","journal-title":"Crit Care"},{"issue":"2","key":"pone.0343752.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246027","article-title":"Procalcitonin, C-reactive protein, neutrophil gelatinase-associated lipocalin, resistin and the APTT waveform for the early diagnosis of serious bacterial infection and prediction of outcome in critically ill children","volume":"16","author":"MJ Nielsen","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"pone.0343752.ref025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1080\/07853890.2022.2091789","article-title":"Clinical assessment of neutrophil gelatinase-associated lipocalin as a potential diagnostic marker for neonatal sepsis: a prospective cohort study","volume":"54","author":"D Midan","year":"2022","journal-title":"Ann Med"},{"issue":"7","key":"pone.0343752.ref026","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00134-018-5228-3","article-title":"Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study","volume":"44","author":"M Parlato","year":"2018","journal-title":"Intensive Care Med"},{"issue":"4","key":"pone.0343752.ref027","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1002\/jcb.27870","article-title":"The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis","volume":"120","author":"M Tan","year":"2019","journal-title":"J Cell Biochem"},{"key":"pone.0343752.ref028","first-page":"23078","article-title":"The Swecrit Biobank, associated clinical registries, and machine learning (artificial intelligence) improve critical care knowledge","volume":"120","author":"A Frigyesi","year":"2023","journal-title":"Lakartidningen"},{"issue":"3","key":"pone.0343752.ref029","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1148\/radiol.2015151516","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"277","author":"PM Bossuyt","year":"2015","journal-title":"Radiology"},{"issue":"11","key":"pone.0343752.ref030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"JF Cohen","year":"2016","journal-title":"BMJ Open"},{"issue":"10","key":"pone.0343752.ref031","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00134-005-2763-5","article-title":"SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission","volume":"31","author":"RP Moreno","year":"2005","journal-title":"Intensive Care Med"},{"issue":"7","key":"pone.0343752.ref032","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"JL Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"8","key":"pone.0343752.ref033","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"pone.0343752.ref034","article-title":"New, useful criteria for assessing the evidence of infection in sepsis research","volume":"4","author":"L Mellhammar","year":"2022","journal-title":"Crit Care Explor"},{"issue":"3","key":"pone.0343752.ref035","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s15010-023-02158-w","article-title":"Sepsis mimics among presumed sepsis patients at intensive care admission: a retrospective observational study","volume":"52","author":"M Lengquist","year":"2024","journal-title":"Infection"},{"issue":"19","key":"pone.0343752.ref036","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without race","volume":"385","author":"LA Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0343752.ref037","doi-asserted-by":"crossref","first-page":"15529","DOI":"10.1038\/s41598-025-95420-0","article-title":"Calprotectin as a sepsis diagnostic marker in critical care: a retrospective observational study","volume":"15","author":"M Lengquist","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"pone.0343752.ref038","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/00365513.2010.486868","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL): validation of commercially available ELISA","volume":"70","author":"KR Pedersen","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"pone.0343752.ref039","volume-title":"R: A language and environment for statistical computing","author":"Team R Core","year":"2024"},{"key":"pone.0343752.ref040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"X Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"pone.0343752.ref041","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016"},{"issue":"1","key":"pone.0343752.ref042","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13054-018-2112-z","article-title":"A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit","volume":"22","author":"E Peters","year":"2018","journal-title":"Crit Care"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:55:56Z","timestamp":1786730156000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343752"}},"subtitle":[],"editor":[{"given":"Hideshi","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343752","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}